Figure 1.
Kaplan–Meier curve of progression‐free survival (PFS) among Japanese patients with advanced biliary tract cancers refractory to gemcitabine, treated with trametinib (all treated patients)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.